Trial on Safety and Pharmacokinetics of Intravaginal Curcumin
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to determine the maximum tolerable dose and safety of
intravaginal curcumin in a normal population of women (women with no evidence of cervical
cytological abnormalities by pap testing).